Alefacept, first biologic agent approved for treatment of psoriasis.
Piascik
Peggy
P
College of Pharmacy, University of Kentucky, Lexington, USA.
D000077944:Alefacept; D002986:Clinical Trials as Topic; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D011993:Recombinant Fusion Proteins; D000077944:Alefacept